Tacrolimus solution (Bay Pharma)

他克莫司溶液 (Bay Pharma)

Report date: 2026/03/04 20:01:44

Base Information

Drug NameTacrolimus solution (Bay Pharma)
Drug Alias NameTACRO-Skin
ClassificationSmall molecules > Molecular GlueSmall molecules > Heterocyclic drugs
Mechanisms of ActionBone morphogenetic protein receptor type-2 modulatorsT cell activation inhibitorsImmunosuppressants +[5] 
TargetsBone morphogenetic protein receptor type-2CytokinesCalcineurin
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyFrance
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesBay Pharma GmbH
China Registration ClassN/A

Develop Information

Active CompaniesBay Pharma GmbH
Inactive CompaniesN/A
Active IndicationsPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A